// App-Quantinova.ai

P12 : Clinical responses, B cell depletion and treatment outcomes following rituximab biosimilar switch in RA: is there value in switching back?

Researchers

Presenter

  • Andrew Melville

Principal Investigators

  • Maya Buch

  • Jackie Nam

  • Paul Emery

  • Benazir Saleem

  • Shouvik Dass

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • Centre for Musculoskeletal Research, University of Manchester, UK, Manchester, UNITED KINGDOM

  • Rheumatology department, Chapel Allerton Hospital, Leeds, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab biosimilar

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved